Features

Hearing Heart Concerns: The Ear as a Cardiovascular ‘Canary’

Monitoring the biometric links between hearing and heart health through wearable devices represents an important advance in proactive health management.

Author Image

By: John A. Martino II

Founder and CEO, synseer

Five biometric domains connect hearing and heart health. Photo: Maruf/stock.adobe.com.

Hearing and heart health might seem like they live in different worlds—one in the ear, the other in the chest. But the body doesn’t operate in silos. The same blood vessels that feed your heart also supply the delicate structures of the inner ear. The same autonomic nervous system that regulates blood pressure and heart rate also influences inner-ear fluid balance, oxygen delivery, inflammation, and stress responses. And the same lifestyle and disease processes—hypertension, diabetes, smoking, sleep disorders, chronic stress—can quietly affect both cardiovascular function and hearing.

In recent years, researchers and clinicians have been paying closer attention to a growing reality: hearing loss is often correlated with cardiovascular risk, and cardiovascular health can influence hearing outcomes.1 This opens up a powerful opportunity: the creation of wearable health devices that monitor the biometric links between hearing and heart health—continuously, passively, and with context—to catch health problems earlier, personalize care, and potentially improve quality of life in two major domains at once. 

We are approaching the tipping point for preventive self-care with today’s consumers increasingly prioritizing extending healthspan over lifespan.2 synseer, a global health and wellness company, is developing a health wearable—HealthBuds—that monitors the biometric links between hearing and heart health, providing a powerful new tool to help consumers take charge of their health. The HealthBuds will be the first device of an ecosystem of connected health wearables that blend medical-grade sensing with agentic AI-based conversational coaching. The company’s aim is to provide consumers with a robust biometric storyline, enabling them to practice more proactive healthcare. 

Why the Ear Is a Cardiovascular ‘Canary

The inner ear (cochlea) acts as a “cardiovascular canary” because its delicate microvascular network is uniquely sensitive to the circulation and oxygenation issues that define heart disease. Small disruptions in this metabolically active organ can have outsized consequences. That means anything that compromises microcirculation—narrowed vessels, reduced oxygen delivery, inflammation, clotting tendencies, or impaired endothelial function—can affect hearing.

Cardiovascular conditions are, at their core, conditions of circulation and regulation. High blood pressure, atherosclerosis, heart failure, arrhythmias, and metabolic disease can all influence how effectively blood reaches microvascular beds throughout the body. The cochlea’s vulnerability makes hearing function a potential “early warning” site for systemic vascular issues.

This does not mean hearing loss always equals heart disease. Hearing loss has many causes: age-related changes, noise exposure, genetic factors, ototoxic medications, infections, autoimmune disorders, and more. But when hearing changes appear alongside certain biometric patterns—elevated blood pressure, reduced heart-rate variability (HRV), impaired oxygenation, high resting heart rate, or poor sleep physiology—the combined picture can hint at a broader cardiometabolic story.

By monitoring these subtle hearing changes alongside systemic biometrics, wearable developers can create an early warning system that detects cardiovascular distress before a major event occurs. This physiological link transforms the ear from an isolated sensory organ into a vital diagnostic window for proactive, whole-body health management

What the Research Trend Suggests (In Plain Terms)

Across many observational studies, poorer cardiovascular health and hearing loss frequently travel together, especially in older adults. Shared biological drivers, such as microvascular damage and inflammation, cause hearing and cardiovascular health to decline in tandem. This data highlights a bi-directional cycle where physiological strain directly impairs the ear, while the resulting hearing loss triggers behavioral stressors that further degrade heart health. The relationships are often strongest with:

  • Hypertension (especially long-standing or poorly controlled)3
  • Atherosclerotic disease and overall vascular risk4
  • Diabetes and insulin resistance5
  • Smoking and chronic inflammation6
  • Reduced fitness and sedentary lifestyle7
  • Sleep-disordered breathing (like obstructive sleep apnea)8

The common thread is microvascular damage, oxidative stress, inflammation, and autonomic dysregulation—biological processes that can affect both the cardiovascular system and the auditory system. The inner ear, with its high energy demand9 and fragile blood supply, may reflect these issues sooner or more noticeably than other organs.

Hearing loss itself can indirectly impact heart health through behavior and stress. Hearing difficulty can lead to social withdrawal, increased loneliness, reduced physical activity, and chronic cognitive load (the “effort” of listening).10-12 Over time, those factors can increase stress hormones, worsen sleep, reduce exercise, and amplify cardiovascular risk. So, the connection can run both ways: the heart influences hearing, and hearing influences the behaviors and physiology that shape heart health. Consequently, these findings prove that monitoring the ear is a scientifically sound strategy for identifying systemic risks and managing whole-body wellness.

Specific biomarkers—such as HRV, oxygenation, and pulse waveforms—construct the “Biometric Bridge” between the ear and the heart. Replacing static clinical snapshots with AI-driven pattern recognition provides the practical framework for transforming hearables into a continuous early warning system for systemic health.

Following are the most relevant biometric domains that connect hearing and heart health:

1. Circulation and Perfusion Indicators

If the cochlea is sensitive to microvascular changes, then metrics that reflect the blood’s ability to circulate and deliver nutrients where needed take on an outsized importance. Common wearable biomarkers include:

  • Resting heart rate (a rough proxy for cardiovascular workload and fitness)
  • Blood pressure trends (increasingly available via cuffless or intermittent methods, though accuracy varies by device)
  • Peripheral perfusion proxies (like pulse waveforms measured either by light waves using photoplethysmography (PPG) or the newer sound wave technology used in synseer’s HealthBuds) 

A consistent pattern of elevated resting heart rate, blood pressure spikes, or degraded pulse-wave characteristics may suggest vascular strain that could also affect inner-ear perfusion

2. Autonomic Nervous System Metrics

HRV reflects how the autonomic nervous system balances sympathetic (fight or flight) and parasympathetic (rest and digest) activity. Low or declining HRV can indicate chronic stress, poor recovery, inflammation, sleep disruption, or cardiometabolic strain.

Why this matters for hearing:

  • Autonomic tone (the baseline activity of the autonomic nervous system) influences vascular regulation and microcirculation.
  • Stress physiology can exacerbate tinnitus perception and listening fatigue.
  • Poor autonomic recovery correlates with worse sleep and higher cardiovascular risk—both relevant to hearing outcomes and cognitive health.

3. Oxygenation and Respiratory Physiology

If oxygen delivery is impaired—by sleep apnea, lung issues, or cardiovascular inefficiency—the cochlea may be affected. Biometrics that help here include:

  • Nocturnal oxygen saturation trends (SpO₂)
  • Sleep breathing irregularities (when detected)
  • Nighttime heart-rate patterns that suggest fragmented sleep

Sleep apnea, in particular, is a major, underdiagnosed risk factor for hypertension, arrhythmias, and vascular disease—and it has also been linked to auditory issues in some research.13 Monitoring nocturnal oxygen dips and sleep fragmentation via wearable health devices can provide actionable signals for further evaluation.

4. Inflammation, Metabolic Signals, and Lifestyle Correlations 

Most consumer health monitoring devices don’t directly measure inflammation or blood glucose accurately without invasive or specialized sensors. But they can track the behaviors and physiological footprints that correlate with metabolic health:

  • Sleep duration and regularity
  • Activity levels, sedentary time, cardio fitness estimates
  • Stress and recovery patterns
  • Weight trends (if entered) and resting heart rate changes

These are not “diagnoses,” but they help build a storyline: sustained poor sleep plus reduced activity plus rising resting heart rate is a pattern worth addressing, especially if hearing difficulties are emerging or worsening. Health wearables that incorporate agentic AI can identify and translate these patterns into actionable steps for consumers to take.

5. Hearing-Focused Biometrics and Functional Measures

Traditional audiograms are snapshots taken in clinics, often years apart. Yet hearing ability can fluctuate with congestion, fatigue, stress, blood pressure changes, and noise exposure. “Hearing biometrics” could include:

  • At-home hearing screening tests (tone detection thresholds, speech-in-noise performance)
  • Listening effort metrics (how often a person increases volume, requests repeats, or struggles in noise)
  • Tinnitus severity tracking (self-report combined with stress/sleep metrics)

When hearing performance data is paired with cardiovascular and autonomic metrics, the relationship can become clearer. For example, does speech-in-noise performance worsen after nights with low oxygen saturation? Do tinnitus spikes align with stress physiology and poor HRV? Does hearing fatigue correlate with higher resting heart rate and poor recovery? By making these important correlations, consumers can gain critical early warning signs. 

The Benefits of Monitoring the Hearing–Heart Connection

Integrated monitoring shifts health management from a reactive model to a proactive, pattern-based system. By providing personalized feedback and closing care gaps, these benefits turn the biological link between the ear and heart into a practical tool for preventing compounding risks like cognitive decline and major cardiovascular events. Following are five ways monitoring the hearing-heart connection could lead to better health outcomes. 

1. Earlier Detection Through “Pattern Recognition”

When people hear “biometric monitoring,” they often think of a single number—like heart rate. But the real value comes from patterns across multiple signals, tracked over time, and interpreted in context. Integrated monitoring shifts health management from a reactive model to a proactive, AI-driven pattern-based system. 

Many cardiovascular problems develop gradually. Early warning signs often show up as subtle shifts: rising resting heart rate, decreasing HRV, worsening sleep metrics, or more frequent blood pressure spikes. If hearing function is also changing during the same window, that paired signal may strengthen the case for timely evaluation. Instead of reacting to a crisis (like a cardiac event or a sudden major decline in hearing), monitoring enables a proactive approach: identify trends, address risk factors, and escalate to clinical care when appropriate.

2. More Personalized Care

Hearing loss is not one-size-fits-all. Two people can have the same audiogram and very different daily experiences. Likewise, two people with the same blood pressure reading can have different underlying risk profiles depending on sleep, stress, fitness, and variability.

Biometric monitoring supports personalization in three ways:

  1. Baseline mapping: What’s normal for you?
  2. Trigger detection: What patterns precede your bad days?
  3. Response tracking: Do interventions actually help?

For example, if improved sleep regularity and exercise increase HRV and reduce tinnitus severity—or stabilize speech-in-noise performance—that’s a measurable, motivating feedback loop. By providing personalized context of biometrics, consumers are able to make better decisions and feel more in control. 

3. Better Decision-Making About Lifestyle and Treatment

People often struggle to sustain behavior change because benefits feel abstract. Biometrics make improvement visible. Seeing that a walking routine lowers resting heart rate and improves sleep, or that reducing alcohol improves overnight oxygenation and morning listening clarity, can turn vague advice into tangible outcomes.

This also supports clinical discussions. A patient who can show six months of trends—sleep fragmentation, oxygen dips, HRV changes, and hearing test results—arrives with richer data than a single office visit can capture. Agentic AI health coaches, such as the one employed in synseer’s HealthBuds, help consumers make sense of the trends and encourage them to see a healthcare professional when warranted.

4. Potential Reduction in Downstream Risks: Falls, Cognitive Load, and Quality of Life

Hearing loss is associated with higher risk of falls and cognitive strain in many populations.14 Cardiovascular health also affects balance and cognition. When hearing and heart health decline together, the downstream impacts can compound.

Monitoring helps by:

  • Identifying periods of higher risk (e.g., poor sleep + low HRV + increased dizziness reports)
  • Encouraging earlier hearing support (like amplification and hearing rehabilitation)
  • Supporting overall health interventions that benefit both systems (exercise, blood pressure management, sleep apnea treatment)

The result isn’t just better hearing or a better heart—it’s better day-to-day functioning.

5. Closing Care Gaps with Continuous, Low-Friction Data

Many people do not receive regular hearing screenings, and many cardiovascular risks go unmanaged until a crisis presents itself. Passive monitoring through wearable devices like earbuds lowers the barrier to awareness. It can also help overcome the “I feel fine” problem, because many risk factors are silent.

This matters most for:

  • Adults over 40 with emerging hearing difficulty
  • People with hypertension, diabetes, or a family history of cardiovascular disease
  • Individuals with sleep apnea risk (snoring, daytime sleepiness, high BMI, resistant hypertension)
  • Those with high noise exposure and high-stress lifestyles

If you’ve ever felt that hearing loss is an “inevitable aging thing,” it’s worth reframing. Some hearing changes may be inevitable, but many are influenced by modifiable factors—circulation, inflammation, metabolic health, sleep, and stress. Likewise, if you’ve ever viewed heart health as something to think about only after a scary event, biometric monitoring offers a quieter, earlier opportunity to pay attention.

These scenarios illustrate the thesis in action, showing how multi-signal patterns transform subtle physiological fluctuations into actionable health insights. By correlating hearing performance with cardiovascular data, these examples demonstrate how the ear functions as a “cardiovascular canary” to trigger timely, potentially life-saving interventions. This practical application shifts care from reactive treatment to a data-driven, preventive model of whole-body health.

Scenario 1: Hearing fatigue and stress physiology

A person notices that meetings feel harder on certain days. Hearing screening results show slightly worse speech-in-noise performance on those days. Biometrics show low HRV and poor sleep the night before. This suggests that listening effort may be amplified by stress and reduced recovery—actionable through sleep hygiene, stress reduction, and potentially hearing support.

Scenario 2: Gradual hearing decline with rising cardiovascular strain

Over six months, a person’s home hearing tests show a slow decline in higher frequencies. At the same time, resting heart rate drifts upward, and blood pressure readings become more variable. This combination may justify a cardiovascular risk review, medication adherence check, and lifestyle intervention—while also prompting earlier hearing evaluation.

Scenario 3: Tinnitus spikes and sleep-disordered breathing

A person reports tinnitus flares that follow “bad sleep.” Biometrics show repeated nocturnal oxygen dips and elevated overnight heart rate. This pattern supports screening for sleep apnea, which—if treated—may improve both cardiovascular risk and subjective tinnitus burden.

The connection between hearing and heart health is not just academic. It’s practical: the ear can reflect vascular well-being, and better hearing can support healthier behavior, lower stress, and stronger social engagement—all of which influence cardiovascular outcomes. These are not guarantees, but they illustrate how multi-signal patterns can guide smarter next steps.

What Monitoring Can and Cannot Do

It’s important to be clear: biometric monitoring does not provide a diagnosis. It’s a decision-support layer. It can flag patterns, quantify change, and create a more complete picture, but it does not replace:

  • A clinical hearing evaluation (audiology exam or tympanometry when needed)
  • Medical evaluation for cardiovascular risk (blood pressure, labs, or ECG when indicated)
  • Assessment for treatable causes (earwax impaction, medication effects, infections, autoimmune issues, thyroid disorders, etc.)

The real power is in combining consumer monitoring with professional care: biometrics help decide when to seek evaluation and how to tailor interventions. Accuracy also matters. Some consumer biometrics—especially cuffless blood pressure estimation—vary widely by device and individual. Devices that employ photoplethysmography (PPG) rather than sound-based technologies only provide intermittent heart metrics. The best approach is trend-based: track changes over time rather than obsessing over single readings and confirm concerns with clinical measurements. 

The Future: Integrated Hearing-Heart Health as Preventive Medicine

We are moving toward a health model that is continuous, personalized, and preventive—where the goal is to detect risk before it becomes disease. This is where consumers are heading and it’s important medical device technology evolve to meet this need. Hearing health monitoring belongs in that model. Hearing loss is common, impactful, and often gradual. Cardiovascular disease remains a leading driver of morbidity. Their overlap is not a coincidence; it’s an opportunity.

In the future, integrated monitoring could support:

  • Routine hearing screening alongside heart and sleep data
  • Early flags for microvascular decline
  • Personalized hearing rehabilitation plans informed by sleep and stress physiology
  • Better adherence to cardiovascular lifestyle changes, reinforced by improvements in listening comfort and social engagement
  • Smarter triage: who needs clinical attention now versus who can start with lifestyle optimization and monitoring

Most importantly, it reframes hearing health as part of whole-body health. Hearing isn’t just about the ears—it’s about brain load, social connection, balance, safety, and vitality. The heart isn’t just about avoiding disease—it’s about energy, resilience, and longevity. Monitoring the biometric links between them turns two separate health conversations into one integrated pathway to better health. Wearable health devices, such as synseer’s HealthBuds, which provide richer, more longitudinal biometrics, help consumers leverage the hearing heart connection to intervene early and maximize their healthspan. 

When consumers can measure the relationship—how sleep, stress, circulation, and recovery relate to real-world hearing performance—they gain leverage. They’re no longer guessing. They can see patterns, respond earlier, and choose interventions with feedback. That’s the true benefit of monitoring: not more data, but better direction.

References

  1. tinyurl.com/mpo260151
  2. tinyurl.com/mpo260152
  3. tinyurl.com/mpo260153
  4. tinyurl.com/mpo260154
  5. tinyurl.com/mpo260155
  6. tinyurl.com/mpo260156
  7. tinyurl.com/mpo260157
  8. tinyurl.com/mpo260158
  9. tinyurl.com/mpo260159
  10. tinyurl.com/mpo260160
  11. tinyurl.com/mpo260161
  12. tinyurl.com/mpo260162
  13. tinyurl.com/mpo260163
  14. tinyurl.com/mpo260164

John A. Martino II is a visionary technologist and serial entrepreneur who has launched seven businesses with three public company exits. His most recent venture is synseer, an intelligent health and wellness company that enables consumers of all ages to practice self-led preventive healthcare through an ecosystem of connected health wearables that blend medical-grade sensing with conversational agentic AI coaching.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters